Question 1

What are the potential side effects of TKI258?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

Question 2

How does TKI258 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma clinical trial (NCT00243763). Contact the study team or your healthcare provider for specific answers.

What this study is about